PRODUCT LITERATURE
Anti-inflammatory Effects of Rebamipide According to Helicobacter pylori Status in Patients with Chronic Erosive Gastritis: A Randomized Sucralfate-Controlled Multicenter Trial in China TARS Study
The aim of the study was to investigate the
effects of rebamipide on symptom, histology, endogenous
prostaglandin, and mucosal oxygen free radicals in chronic
erosive gastritis (CEG) patients by using sucralfate as a
control. The trial also examined whether Helicobacter
pylori infection would affect rebamipide-induced protection. A total of 453 endoscopy-confirmed CEG patients from
11 hospitals in China were enrolled in the study
No other version available